Will there be a surprise?
The delay of the NR may bode well for CRH and its shareholders. If I am not mistaken, CRH was supposed to exercise an option to acquire some facility in the West, Seattle or Oregon in the first quarter of 2018. The deal was that CRH would foot the cost of installing the facilities, training etc. to this big medical facility, for deep sedation procedures and if the experiment was successful, they would acquire 51% of the business without extra cost. If this plan materialized, the acquisition because of its size and scope, would be a company maker. I tried to trace back this info in the 2016, and 2017 NR, but with no luck. If anyone has it, please let us know. But I remember the first q of 2018 was the time CRH was to exercise this option with no extra cost to the co.